Previous Article | Next Article ![]()
Infection and Immunity, December 2001, p. 7889-7893, Vol. 69, No. 12
Institut für Medizinische Mikrobiologie
und Hygiene, Universitätsklinikum Mannheim, Universität
Heidelberg, Mannheim,1 and Abteilung
für Neuropathologie, Universität zu Köln,
Cologne,2 Germany, and Neurochirurgie,
Universitätsspital Zürich, Zürich,
Switzerland3
Received 10 April 2001/Returned for modification 29 May
2001/Accepted 27 August 2001
The intracellular parasite Toxoplasma
gondii has the capacity to persist in the brain within
neurons. In this study we demonstrated that T. gondii
infected murine cerebellar neurons in vitro and replicated within these
cells. Stimulation with gamma interferon (IFN- Toxoplasma
gondii is an obligate intracellular protozoan parasite which
persists in the host central nervous system (CNS). Electron microscopic
studies of animals with murine toxoplasmosis have identified neurons as
the primary target cells for T. gondii, although astrocytes
and microglia can also be infected by T. gondii (3, 7,
12, 15).
Studies of experimental murine toxoplamosis have identified gamma
interferon (IFN- Invasion and multiplication of T. gondii in neurons
and modulation by IFN-
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.12.7889-7893.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Toxoplasma gondii Infection of Neurons Induces
Neuronal Cytokine and Chemokine Production, but Gamma Interferon- and
Tumor Necrosis Factor-Stimulated Neurons Fail To Inhibit the
Invasion and Growth of T. gondii
![]()
ABSTRACT
Top
Abstract
Text
References
) and/or tumor
necrosis factor (TNF) did not enable neurons to inhibit parasite
invasion and replication. Cultured neurons constitutively produced
interleukin 1 (IL-1), IL-6, macrophage inflammatory protein 1
(MIP-1
), and MIP-1
but not transforming growth factor
1
(TGF-
1), IL-10, and granulocyte-macrophage colony-stimulating factor. Neuronal expression of some cytokines (IL-6, TGF-
1) and chemokines (MIP-1
) was regulated by infection and/or by IFN-
and TNF.
![]()
TEXT
Top
Abstract
Text
References
) production by both CD4+ and
CD8+ T cells as a key factor for parasite control
(11, 27, 29). In addition, tumor necrosis factor (TNF),
which is produced by CD4+ and
CD8+ T cells, macrophages, microglial cells, and
some astrocytes in animals with Toxoplasma encephalitis
(22), contributes to the control of T. gondii
in cerebral toxoplasmosis (10). Although the importance of
IFN-
and TNF has been delineated, the mechanisms which control the
parasite in neurons have been determined only incompletely. In
particular, it is still not known whether IFN-
and TNF directly or
indirectly control intraneuronal T. gondii. In addition, the
detailed immunological response of neurons to parasite infection is
still not known. To gain more insight into the interaction of T. gondii with neurons, we studied parasite invasion and replication
in cultivated murine CNS neurons and neuronal cytokine and chemokine
production in response to infection with T. gondii, as well
as the regulatory effect of IFN-
and TNF on these processes.
and/or TNF.
Cerebellar granule neurons
were isolated from the brains of 7-day-old BALB/c mice as described
previously (19, 20). Neurons were added at a concentration
of 5.2 × 105 cells per well to
poly-L-lysine-coated 24-well plates. Neurons were cultured
in basal medium Eagle (BME) supplemented with 10% fetal calf serum
(FCS), 25 mM K+, 2 mM L-glutamine, 30 mM glucose, and 50 µg of gentamicin per ml (all obtained from Sigma,
Deisenhofen, Germany). To stop the growth of nonneuronal cells, 10 µM
cytosine-
-arabinoside (Sigma) was added on day 1 after plating of
neurons. Immunofluorescence revealed that the cultures contained
approximately 95% neurofilament-positive neurons and 5% glial
fibrillary acid protein (GFAP)-positive astrocytes. Neurons that
were 7 days old were infected with tachyzoites of the RH strain of
T. gondii at a multiplicity of infection (MOI) of 0.1, 1, or
10. RH toxoplasms were grown on human foreskin fibroblasts in
Dulbecco's modified Eagle medium supplemented with 10% FCS. For infection of neurons, parasites, which had lysed fibroblasts just
before the experiments, were washed with Hanks balanced salt solution
supplemented with 3% FCS and were added to neuronal cell tissue
cultures. Portions of the neuronal cell cultures were treated with
IFN-
(100 U/ml; Pharmingen) and/or TNF (10 U/ml; Pharmingen) for
12 h prior to infection with T. gondii. To determine
the number of T. gondii-infected neurons and the number of
T. gondii cells per parasitophorous vacuole (PV), neurons
were fixed with 4% paraformaldehyde either 24 or 48 h after
infection. After this, neurons were stained with rabbit anti-T.
gondii antiserum and then with peroxidase-coupled goat anti-rabbit
immunoglobulin G F(ab)2 fragments. The reaction product was visualized by incubation with
H2O2 and
3,3-diaminobenzidine (Sigma). The number of infected neurons and the
number of parasites per PV were determined by examining at least 100 neurons per well.
or TNF or with both
cytokines did not reduce the percentage of infected neurons (Table 1).
At 24 h postinfection, most infected neurons harbored one or two
parasites per PV, and only a low percentage of neurons contained more
parasites per PV (Fig. 2A). Again,
pretreatment of neurons with IFN-
or TNF or with both cytokines did
not significantly change the number of parasites per PV. At 48 h
postinfection, the numbers of parasites per PV had increased equally in
all experimental groups (Fig. 2B) (P < 0.01 for each
experimental group at 48 h postinfection compared to the
corresponding group 24 h postinfection, as determined by the
Wilcoxon test), and the numbers of parasites per PV in untreated and
cytokine-treated neurons did not differ significantly. An increase in
the concentration of IFN-
from 100 to 500 U/ml also did not inhibit
parasite invasion and multiplication in neurons, whereas a TNF dose
greater than 10 U/ml (i.e., 100 U/ml) was found to be toxic for
neurons, especially when it was combined with IFN-
(data not shown).
Thus, neurons were not able to restrict invasion and growth of T. gondii, and treatment of neurons with IFN-
and/or TNF did not
induce toxoplasmastatic activity in these cells, although
neurons are known to express the receptors for IFN-
and TNF and
respond to this stimulation by induction of major histocompatibility
complex class I expression (18, 21, 24) as well as
cytokine and chemokine production (see below).

View larger version (0K):
[in a new window]
FIG. 1.
Cultured cerebellar neurons after infection with
T. gondii RH (MOI, 1) for 48 h: PV containing
numerous tachyzoites in the cytoplasm of a neuron with a prominent
nucleolus. Note the intimate contact of the PV with the nuclear
membrane. Anti-T. gondii immunostaining and slight
counterstaining with hemalum were used. Magnification, ×625.
TABLE 1.
Levels of infection of neurons

View larger version (21K):
[in a new window]
FIG. 2.
Proliferation of T. gondii in neurons
24 h (A) and 48 h (B) after infection. After 7 days of
cultivation neurons were treated with the cytokines indicated for
12 h. After this, RH toxoplasms were added at an MOI of 1. At 24 and 48 h after infection neurons were fixed with 4%
paraformaldehyde, and T. gondii was stained
immunohistochemically. The number of toxoplasms per PV was determined
microscopically for 100 infected neurons per group; the data are
means ± standard deviations based on three wells per group.
Similar data were obtained in two repeat experiments.
IFN-
and TNF modulate cytokine production in T.
gondii-infected neurons.
Selective isolation and
cultivation of neurons enabled us to study for the first time cytokine
and chemokine production in T. gondii-infected neurons. To
analyze whether T. gondii infection of neurons induces
production of cytokines and chemokines in neurons, a panel of these
mediators was studied 48 h postinfection (Fig. 3). To detect cytokines and chemokines,
commercially available enzyme-linked immunosorbent assays were used as
recommended by the manufacturers. Interleukin 1
(IL-1
) and IL-6
assays were obtained from Biosource, Lucerne Chem AG, Lucerne,
Switzerland; IL-10 and granulocyte-macrophage colony-stimulating factor
(GM-CSF) assays were obtained from Endogen Inc., Boston, Mass.; and
macrophage inflammatory protein 1
(MIP-1
), MIP-1
, transforming
growth factor
1 (TGF-
1), and TGF-
2 assays were obtained
from R&D Systems, RNT Systems, London, United Kingdom. The
Wilcoxon test was used for statistical evaluation of the cytokine
and chemokine data. Uninfected murine cerebellar neurons produced
significant amounts of IL-1
, IL-6, and TGF-
2, which is consistent
with the results of previous studies (5, 22). Infection of
neurons with T. gondii and treatment with IFN-
and/or TNF
did not modulate IL-1
and TGF-
2 production. The low basal level
of production of IL-6 was slightly upregulated by infection and by
treatment with IFN-
and IFN-
plus TNF (P < 0.05 for infected and IFN-
- and IFN-
-TNF-stimulated neurons compared
to the corresponding noninfected groups). In contrast, TGF-
1
production was significantly induced by infection of neurons
(P < 0.01 for both infected nonstimulated neurons and infected IFN-
-treated neurons compared to the corresponding
uninfected groups; P < 0.05 for infected
TNF-stimulated neurons compared to uninfected TNF-stimulated neurons)
and declined in response to treatment with IFN-
and/or TNF
(P < 0.05 for infected IFN-
-stimulated neurons
compared to infected nonstimulated neurons; P < 0.01 for infected TNF-stimulated neurons compared to infected nonstimulated neurons). In addition to cytokines, neurons also produced MIP-1
, which was upregulated by infection with T. gondii
(P < 0.05 for all groups of infected neurons compared
to the corresponding groups of uninfected neurons), but production was
not further increased by cytokine application. In contrast, MIP-1
expression in uninfected neurons was gradually upregulated by treatment
with IFN-
, TNF, and IFN-
plus TNF and was further increased by
T. gondii infection (P < 0.05 for infected
nonstimulated, IFN-
-stimulated, and TNF-stimulated neurons compared
to the corresponding uninfected neurons; P < 0.01 for
infected IFN-
-TNF-stimulated neurons compared to uninfected IFN-
-TNF-stimulated neurons; P < 0.05 for infected
IFN-
-stimulated neurons compared to infected nonstimulated neurons;
P < 0.05 for both uninfected and infected
TNF-stimulated neurons compared to the corresponding groups of
nonstimulated neurons; P < 0.01 for both infected and
uninfected IFN-
-TNF-stimulated neurons compared to the
corresponding groups of nonstimulated neurons). In contrast to the
production of cytokines and chemokines mentioned above, neurons did not
produce IL-10 and GM-CSF (data not shown). Since IL-10 and GM-CSF are
produced by T. gondii-infected microglial cells and
astrocytes, respectively (9), these findings further illustrate the purity of the neuronal cell cultures.
|
and/or TNF does not
inhibit parasite invasion and replication in neurons. The level of
infected neurons was relatively high compared to data reported by
Fagard et al. (6) for rat hippocampal neurons. However, as
discussed by these authors, murine neurons may be better target cells
for toxoplasms than rat neurons. The lack of IFN-
and/or TNF
activity that inhibits parasite invasion and replication in neurons is
in marked contrast to the findings obtained for other CNS resident
cells (i.e., astrocytes and microglia), which effectively restrict
multiplication of T. gondii following stimulation with
either IFN-
or a combination of IFN-
and TNF (4,
12). Interestingly, studies performed with murine bone marrow
chimeras have revealed that expression of IFN-
receptors and TNF
receptors on both hematopoietic and radioresistant host cells,
including microglia, astrocytes, and neurons, is required for efficient
control of T. gondii (30). However, infection of mixed cultures of neurons, astrocytes, microglia, and
oligodendrocytes with T. gondii resulted in spontaneous,
IFN-
-independent encystation of parasites within neurons and
astrocytes (8, 16). Collectively, these findings and our
observations indicate that IFN-
and TNF play an important role in
control of T. gondii in microglia and astrocytes but are not
enough to control this parasite in neurons. The mechanisms that
underlie astrocyte-microglia-mediated control of intraneuronal
parasite replication have not been determined yet but may include
soluble factors as diverse as neurotrophins like nerve growth factor,
which has a strong immunoregulatory capacity (25, 26), and
microglia-derived leukotrienes (17), which have been shown
to have toxoplasmastatic activity in mast cells and macrophages
(13, 31).
The neuronal production of the CC chemokines MIP-1
and
MIP-1
, which can attract T cells, macrophages, and granulocytes
(1), indicates that tachyzoite-infected neurons contribute
to the recruitment of inflammatory leukocytes to the site of the
offending pathogen. In fact, intracellular toxoplasms are generally
surrounded by an infiltrate composed of T cells, macrophages, and some
granulocytes (23). However, immunohistochemical studies of
murine Toxoplasma encephalitis have shown that some
bradyzoite-containing cysts are not accompanied by inflammatory
leukocytes (23), which suggests that neuronal production
of chemokines may depend on the growth stage of T. gondii. The production of IL-1
and IL-6 by neurons indicates
that neurons contribute to intracellular parasite control, since both
of these cytokines are important for the control of cerebral toxoplasms
(14, 28). In addition, neuron-derived TGF-
2, an
immunosuppressive cytokine which is also produced after infection of
peritoneal macrophages with T. gondii (2), may contribute to regulation of the intracellular immune response. The
regulatory activities of both IFN-
and TNF during neuronal cytokine
and chemokine production illustrate that neurons are also integrated
via this pathway into the complex neuroimmunological network that
provides protection against offending toxoplasms.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grant Schl 392/2-3 from the Deutsche Forschungsgemeinschaft to D. Schlüter.
We thank N. Kaefer for expert technical assistance and H. Klatt for photographic help.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institut für Medizinische Mikrobiologie und Hygiene, Universitätsklinikum Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Phone: (49) 621-383-2036. Fax: (49) 621-383-3886. E-mail: dirk.schlueter{at}imh.ma.uni-heidelberg.de.
Editor: S. H. E. Kaufmann
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Asensio, V. C., and I. L. Campbell. 1999. Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci. 22:504-512[CrossRef][Medline]. |
| 2. |
Bermudez, L. E.,
G. Covaro, and J. Remington.
1993.
Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors.
Infect. Immun.
61:4126-4130 |
| 3. | Chao, C. C., W. R. Anderson, S. Hu, G. Gekker, A. Martella, and P. K. Peterson. 1993. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism. Clin. Immunol. Immunopathol. 67:178-183[CrossRef][Medline]. |
| 4. | Chao, C. C., S. Hu, G. Gekker, W. J. Novick, Jr., J. S. Remington, and P. K. Peterson. 1993. Effects of cytokines on multiplication of Toxoplasma gondii in microglial cells. J. Immunol. 150:3404-3410[Abstract]. |
| 5. | Constam, D. B., P. Schmid, A. Aguzzi, M. Schachner, and A. Fontana. 1994. Transient production of TGF-beta 2 by postnatal cerebellar neurons and its effect on neuroblast proliferation. Eur. J. Neurosci. 6:766-778[CrossRef][Medline]. |
| 6. | Fagard, R., H. Van Tan, C. Creuzet, and H. Pelloux. 1999. Differential development of Toxoplasma gondii in neural cells. Parasitol. Today 15:504-507[CrossRef][Medline]. |
| 7. | Ferguson, D. J., and W. M. Hutchison. 1987. The host-parasite relationship of Toxoplasma gondii in the brains of chronically infected mice. Virchows Arch. A Pathol. Anat. Histopathol. 411:39-43[CrossRef][Medline]. |
| 8. | Fischer, H. G., B. Nitzgen, G. Reichmann, U. Gross, and U. Hadding. 1997. Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol. Res. 83:637-641[CrossRef][Medline]. |
| 9. | Fischer, H. G., B. Nitzgen, G. Reichmann, and U. Hadding. 1997. Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells. Eur. J. Immunol. 27:1539-1548[Medline]. |
| 10. | Gazzinelli, R. T., I. Eltoum, T. A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151:3672-3681[Abstract]. |
| 11. | Gazzinelli, R. T., F. T. Hakim, S. Hieny, G. M. Shearer, and A. Sher. 1991. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286-292[Abstract]. |
| 12. |
Halonen, S. K.,
F. Chiu, and L. M. Weiss.
1998.
Effect of cytokines on growth of Toxoplasma gondii in murine astrocytes.
Infect. Immun.
66:4989-4993 |
| 13. | Henderson, W. R., Jr., and E. Y. Chi. 1998. The importance of leukotrienes in mast cell-mediated Toxoplasma gondii cytotoxicity. J. Infect. Dis. 177:1437-1443[Medline]. |
| 14. | Jebbari, H., C. W. Roberts, D. J. Ferguson, H. Bluethmann, and J. Alexander. 1998. A protective role for IL-6 during early infection with Toxoplasma gondii. Parasite Immunol. (Oxford) 20:231-239. |
| 15. |
Jones, T. C.,
K. A. Bienz, and P. Erb.
1986.
In vitro cultivation of Toxoplasma gondii cysts in astrocytes in the presence of gamma interferon.
Infect. Immun.
51:147-156 |
| 16. | Luder, C. G., M. Giraldo-Velasquez, M. Sendtner, and U. Gross. 1999. Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation. Exp. Parasitol. 93:23-32[CrossRef][Medline]. |
| 17. | Matsuo, M., Y. Hamasaki, F. Fujiyama, and S. Miyazaki. 1995. Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res. 685:201-204[CrossRef][Medline]. |
| 18. |
Neumann, H.,
H. Schmidt,
A. Cavalie,
D. Jenne, and H. Wekerle.
1997.
Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha.
J. Exp. Med.
185:305-316 |
| 19. | Piani, D., M. Spranger, K. Frei, A. Schaffner, and A. Fontana. 1992. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory amino acids rather than reactive oxygen intermediates and cytokines. Eur. J. Immunol. 22:2429-2436[Medline]. |
| 20. | Rensing-Ehl, A., U. Malipiero, M. Irmler, J. Tschopp, D. Constam, and A. Fontana. 1996. Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur. J. Immunol. 26:2271-2274[Medline]. |
| 21. | Robertson, B., G. Kong, Z. Peng, M. Bentivoglio, and K. Kristensson. 2000. Interferon-gamma-responsive neuronal sites in the normal rat brain: receptor protein distribution and cell activation revealed by Fos induction. Brain Res. Bull. 52:61-74[CrossRef][Medline]. |
| 22. | Schluter, D., N. Kaefer, H. Hof, O. D. Wiestler, and M. Deckert-Schluter. 1997. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am. J. Pathol. 150:1021-1035[Abstract]. |
| 23. | Schluter, D., J. Lohler, M. Deckert, H. Hof, and G. Schwendemann. 1991. Toxoplasma encephalitis of immunocompetent and nude mice: immunohistochemical characterisation of Toxoplasma antigen, infiltrates and major histocompatibility complex gene products. J. Neuroimmunol. 31:185-198[CrossRef][Medline]. |
| 24. | Sipe, K. J., D. Srisawasdi, R. Dantzer, K. W. Kelley, and J. A. Weyhenmeyer. 1996. An endogenous 55 kDa TNF receptor mediates cell death in a neural cell line. Brain Res. Mol. Brain Res. 38:222-232[Medline]. |
| 25. | Stanisz, A. M., and J. A. Stanisz. 2000. Nerve growth factor and neuroimmune interactions in inflammatory diseases. Ann. N. Y. Acad. Sci. 917:268-272[Medline]. |
| 26. |
Susaki, Y.,
S. Shimizu,
K. Katakura,
N. Watanabe,
K. Kawamoto,
M. Matsumoto,
M. Tsudzuki,
T. Furusaka,
Y. Kitamura, and H. Matsuda.
1996.
Functional properties of murine macrophages promoted by nerve growth factor.
Blood
88:4630-4637 |
| 27. | Suzuki, Y., F. K. Conley, and J. S. Remington. 1989. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. J. Immunol. 143:2045-2050[Abstract]. |
| 28. | Suzuki, Y., S. Rani, O. Liesenfeld, T. Kojima, S. Lim, T. A. Nguyen, S. A. Dalrymple, R. Murray, and J. S. Remington. 1997. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice. Infect. Immun. 65:2339-2345[Abstract]. |
| 29. | Suzuki, Y., and J. S. Remington. 1990. The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. J. Immunol. 144:1954-1956[Abstract]. |
| 30. |
Yap, G. S., and A. Sher.
1999.
Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.
J. Exp. Med.
189:1083-1092 |
| 31. |
Yong, E. C.,
E. Y. Chi, and W. R. Henderson, Jr.
1994.
Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity.
J. Exp. Med.
180:1637-1648 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»